Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
PCSK9: from biology to clinical applications
HTML
PDF
Details
Locations
Year:
2018
Type:
review
Source:
Pathology
DOI:
10.1016/j.pathol.2018.10.012
Authors:
Valentin Blanchard,
Ilya Khantalin,
Stéphane Ramin-Mangata,
Kévin Chémello,
Brice Nativel,
Gilles Lambert
show all 6
Institutions:
Inserm,
University of Reunion Island,
Diabète athérothrombose et thérapies Réunion Océan Indien,
Centre Hospitalier Universitaire de La Réunion
Language:
English
Topic:
Lipoproteins and Cardiovascular Health
Subfield:
Cardiology and Cardiovascular Medicine
Field:
Medicine
Domain:
Health Sciences
Keywords:
PCSK9,
PCSK9 inhibitors,
LDL cholesterol,
LDL receptor degradation,
LDL receptor,
hypercholesterolemia,
cardiovascular disease,
drug safety and efficacy
show all 8
SDG:
Good health and well-being
Open Access status:
bronze
Funders:
Amgen,
Pfizer,
Sanofi,
Regeneron Pharmaceuticals,
Agence Nationale de la Recherche
Award:
CHOPIN
OpenAlex ID:
W2902823488
FWCI:
1.188
Cites:
76
Cited by:
47
Related to:
10